invitros

  Invitros has proactively practiced ESG initiatives for sustainable growth. Followings are the ESG initiatives implemented in the first half of 2025:         1. Greenhouse Gas Reduction and Energy Savings through Optimization of HVAC Systems Invitros recognizes the severity of the climate change and is continuously striving to reduce greenhouse gases. At the Invitros Osong Plant, we are continuously optimizing the operation of the HVAC systems, thereby achieving both a reduction in greenhouse gas emissions and saving significant amount of energy.         Invitros has achieved substantial reductions in power consumption by optimizing the operation of its HVAC systems. This was accomplished through the implementation of inverter frequency control devices and comprehensive TAB (Testing, Adjusting, Balancing) process. Furthermore, the improvements to the duct system have increased the waste heat recovery rates, leading to an even greater decrease in power consumption at the Osong Plant. These efforts resulted in an annual electricity consumption reduction of 380 MWh, which translates to a yearly reduction of 173 tons of greenhouse gas emissions compared to last year (savings based on the Ministry of Environment’s power emission coefficient of 0.4541 t CO2eq/MWh in 2024). Beyond the impressive greenhouse gas reductions, these optimization efforts have also led to a significant decrease in steam usage, resulting in the additional benefit of reduced wastewater discharge.             2. Emergency Evacuation Drills Conducted at Seoul Office, R&D Center, and Osong Plant   At Invitros, all employees and customers are fundamental to the company-wide ESG policy. We strive to effectively maintain an environmental, health, and safety (EHS) system to ensure the well-being of everyone at our facilities. In the first half of 2025, we conducted emergency evacuation (fire) drills tailored to the specific conditions of both our Seoul Office, R&D Center, and the Osong Plant.    
    Invitros has established an emergency response manual based on our firm-wide environmental, health, and safety (EHS) system and we conduct regular drills accordingly. Through this emergency evacuation (fire) drill, all employees had the opportunity to re-evaluate and refine how they can respond to emergency situations. As a result, they are well prepared to protect both themselves and our visitors in the event of an emergency evacuation.           3. Supporting the Next Generation: Employee Child School Admission Gift Program       Invitros is committed to bringing joy to our employees’ families and actively supporting the growth and education of the next generation, who will shape the future of our society. To help children prepare for their new school, we provide special gifts upon their school admission. This year, we celebrated the bright new beginnings of five children entering elementary school and university by presenting them with congratulatory gifts. This initiative goes beyond simple support; it’s a sincere expression of interest in our employee’s families and a firm commitment to nurturing future talent. Helping our children pursue their dreams and fulfill their potential is a crucial social value that Invitros strives to achieve.     Thank you.    

 LG Chem has launched a reagent that can check 93 allergy-causing substances, up sharply from the current 62, the company said Thursday.

In 2008, LG Chem released the “AdvanSure™ AlloScreen reagent,” a multi-drug substance-testing product, for the first time in Korea, through research and development on the diagnosis of allergies with Yonsei University Medical School.

The products launched this year added house dust mites, pollen allergies, and substances unique to Koreans through continuous research.

In particular, this reagent expands from 62 existing elements, enabling 93 kinds of materials to be inspected simultaneously with a drop of blood in three hours, saving time and cost of inspection, as well as providing food and the respiratory origin, while identifying the cause of the substance.

Allergies are types of autoimmune diseases that cause hypersensitivity reactions to external substances. It causes allergic asthma, eczema, and rhinitis, with symptoms such as a runny nose, and itchiness that distributes to many patients throughout the world.

Methods for treating allergies include the use of antihistamines, steroids, and immunotherapy, the most efficient and easiest way.

The domestic market is estimated to be about 25 billion won ($21 million), with the number of patients increasing every year due to the effects of fine dust and environmental hormones. Allergies caused by two or more causes are also increasing, making it necessary to know what causes allergens before they appear, the company said. (2017.08.10)

[Link: https://www.koreabiomed.com/news/articleView.html?idxno=1055]